| scholarly article | Q13442814 |
| P2093 | author name string | Virginie Bottero | |
| Judith A Potashkin | |||
| Jose A Santiago | |||
| P2860 | cites work | Link Between Chronic Bacterial Inflammation and Alzheimer Disease | Q22241319 |
| Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients | Q24631987 | ||
| Common mechanisms involved in Alzheimer's disease and type 2 diabetes: a key role of chronic bacterial infection and inflammation | Q26766681 | ||
| FOXO3: A Major Gene for Human Longevity--A Mini-Review | Q26996592 | ||
| Global prevalence of diabetes: estimates for the year 2000 and projections for 2030 | Q27860575 | ||
| Protein misfolding, functional amyloid, and human disease | Q28131732 | ||
| Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins | Q28168105 | ||
| Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium | Q28252389 | ||
| De-repression of FOXO3a death axis by microRNA-132 and -212 causes neuronal apoptosis in Alzheimer's disease | Q28568220 | ||
| Ontology-Based Meta-Analysis of Global Collections of High-Throughput Public Data | Q28749098 | ||
| Neurodegenerative diseases target large-scale human brain networks | Q29614723 | ||
| TLR4 links innate immunity and fatty acid-induced insulin resistance | Q29617577 | ||
| NetworkAnalyst for statistical, visual and network-based meta-analysis of gene expression data | Q30945958 | ||
| Dissecting the Molecular Mechanisms of Neurodegenerative Diseases through Network Biology | Q33734563 | ||
| Alzheimer's disease is type 3 diabetes-evidence reviewed | Q34020000 | ||
| The 21st century epidemic: infections as inductors of neuro-degeneration associated with Alzheimer's Disease | Q34706979 | ||
| Integrative network analysis unveils convergent molecular pathways in Parkinson's disease and diabetes | Q35078279 | ||
| Deficiency in neuronal TGF-beta signaling promotes neurodegeneration and Alzheimer's pathology | Q35112497 | ||
| Historic evidence to support a causal relationship between spirochetal infections and Alzheimer's disease | Q35442946 | ||
| Intrathecal inflammation precedes development of Alzheimer's disease | Q35476365 | ||
| A novel multi-tissue RNA diagnostic of healthy ageing relates to cognitive health status | Q36032418 | ||
| Risk of dementia in diabetes mellitus: a systematic review | Q36345254 | ||
| Type 2 Diabetes as a Risk Factor for Dementia in Women Compared With Men: A Pooled Analysis of 2.3 Million People Comprising More Than 100,000 Cases of Dementia | Q36490441 | ||
| Inflammation in Alzheimer disease: driving force, bystander or beneficial response? | Q36589042 | ||
| Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses | Q36605276 | ||
| Molecular connexions between dementia and diabetes. | Q36837972 | ||
| Age, APOE and sex: Triad of risk of Alzheimer's disease | Q36998533 | ||
| Regulation of forkhead transcription factor FoxO3a contributes to calorie restriction-induced prevention of Alzheimer's disease-type amyloid neuropathology and spatial memory deterioration | Q37020746 | ||
| Risk of incident Alzheimer's disease in diabetic patients: a systematic review of prospective trials | Q37455807 | ||
| Blood Transcriptomic Meta-analysis Identifies Dysregulation of Hemoglobin and Iron Metabolism in Parkinson' Disease | Q37729558 | ||
| Dysfunction of TGF-β1 signaling in Alzheimer's disease: perspectives for neuroprotection. | Q37924158 | ||
| Molecular links between Alzheimer's disease and diabetes mellitus | Q38122603 | ||
| Establishing genomic/transcriptomic links between Alzheimer's disease and type 2 diabetes mellitus by meta-analysis approach. | Q38140970 | ||
| Insulin, incretins and other growth factors as potential novel treatments for Alzheimer's and Parkinson's diseases | Q38197368 | ||
| System-based approaches to decode the molecular links in Parkinson's disease and diabetes | Q38203432 | ||
| A network approach to clinical intervention in neurodegenerative diseases | Q38278681 | ||
| Soluble TREM2 induces inflammatory responses and enhances microglial survival. | Q38402630 | ||
| The Cellular Phase of Alzheimer's Disease | Q38731102 | ||
| Liraglutide prevents beta-amyloid-induced neurotoxicity in SH-SY5Y cells via a PI3K-dependent signaling pathway | Q38775835 | ||
| Dysfunction of TGF-beta signaling in Alzheimer's disease | Q38905027 | ||
| TLR4 is a link between diabetes and Alzheimer's disease. | Q38945704 | ||
| The infectious etiology of Alzheimer's Disease | Q39178926 | ||
| Mitochondrial dysfunction and immune activation are detectable in early Alzheimer's disease blood | Q39634019 | ||
| Helicobacter pylori infection is associated with type 2 diabetes among a middle- and old-age Chinese population | Q41109290 | ||
| Integrative transcriptomic meta-analysis of Parkinson's disease and depression identifies NAMPT as a potential blood biomarker for de novo Parkinson's disease | Q41215282 | ||
| Comorbidity Analysis between Alzheimer's Disease and Type 2 Diabetes Mellitus (T2DM) Based on Shared Pathways and the Role of T2DM Drugs | Q42363364 | ||
| A blood gene expression marker of early Alzheimer's disease | Q42671499 | ||
| Helicobacter pylori prevalence in diabetes mellitus patients with dyspeptic symptoms and its relationship to glycemic control and late complications | Q44879796 | ||
| Blood genome-wide transcriptional profiles reflect broad molecular impairments and strong blood-brain links in Alzheimer's disease | Q45867306 | ||
| The neuroprotection of insulin on ischemic brain injury in rat hippocampus through negative regulation of JNK signaling pathway by PI3K/Akt activation | Q46600045 | ||
| Insulin modulates hippocampal activity-dependent synaptic plasticity in a N-methyl-d-aspartate receptor and phosphatidyl-inositol-3-kinase-dependent manner | Q46644037 | ||
| Biological and Clinical Implications of Comorbidities in Parkinson's Disease | Q47137783 | ||
| The DifferentialNet database of differential protein-protein interactions in human tissues | Q47148160 | ||
| Apolipoprotein E4 Impairs Neuronal Insulin Signaling by Trapping Insulin Receptor in the Endosomes | Q47731042 | ||
| Green Tea Polyphenol EGCG Upregulates Tollip Expression by Suppressing Elf-1 Expression | Q47734890 | ||
| Helicobacter pylori infection associated with high HbA1c and type 2 diabetes | Q47951955 | ||
| Downregulation of protein phosphatase 2A by apolipoprotein E: Implications for Alzheimer's disease | Q48190119 | ||
| Herpesviruses in brains in Alzheimer's and Parkinson's diseases | Q48238285 | ||
| Diabetes as a risk factor for Alzheimer's disease: insulin signalling impairment in the brain as an alternative model of Alzheimer's disease | Q49015193 | ||
| Vascular factors predict rate of progression in Alzheimer disease. | Q50658701 | ||
| Lixisenatide rescues spatial memory and synaptic plasticity from amyloid β protein-induced impairments in rats. | Q50683857 | ||
| Phosphorylation of SET mediates apoptosis via P53 hyperactivation and NM23-H1 nuclear import. | Q54977523 | ||
| Gene Expression in Peripheral Blood Mononuclear Cells from Children with Diabetes | Q57063478 | ||
| Apolipoprotein E Alleles and Risk of Coronary Disease | Q57740650 | ||
| Type 2 Diabetes Mellitus and Alzheimer's Disease: Role of Insulin Signalling and Therapeutic Implications | Q57791805 | ||
| Cross-disease analysis of Alzheimer's disease and type-2 Diabetes highlights the role of autophagy in the pathophysiology of two highly comorbid diseases | Q64118356 | ||
| Dexamethasone-induced Krüppel-like factor 9 expression promotes hepatic gluconeogenesis and hyperglycemia | Q64374695 | ||
| The pathological process underlying Alzheimer's disease in individuals under thirty | Q82953907 | ||
| MFG-E8 reverses microglial-induced neurotoxic astrocyte (A1) via NF-κB and PI3K-Akt pathways | Q90750023 | ||
| Atherosclerosis, Hypertension, and Diabetes in Alzheimer's Disease, Vascular Dementia, and Mixed Dementia: Prevalence and Presentation | Q91160668 | ||
| Taking KLF9 to "Cort" for crimes against metabolism | Q91596401 | ||
| Key inflammatory pathway activations in the MCI stage of Alzheimer's disease | Q92234249 | ||
| Genetic risk for Alzheimer's disease and functional brain connectivity in children and adolescents | Q92383856 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| P304 | page(s) | 1273 | |
| P577 | publication date | 2019-11-29 | |
| P1433 | published in | Frontiers in Neuroscience | Q2177807 |
| P1476 | title | Transcriptomic and Network Analysis Highlight the Association of Diabetes at Different Stages of Alzheimer's Disease | |
| P478 | volume | 13 |
| Q90461702 | Transcriptomic and Network Analysis Identifies Shared and Unique Pathways across Dementia Spectrum Disorders | cites work | P2860 |
Search more.